Skip to main content
. 2023 Nov 8;39(6):944–955. doi: 10.1093/ndt/gfad237

Table 2:

Glucocorticoid dosing (mg/day, prednisolone equivalent) with rituximab- or cyclophosphamide-based regimens for remission induction according to the PEXIVAS study [16].

Week <50 kg 50–75 kg >75 kg
1 50 60 75
2 25 30 40
3–4 20 25 30
5–6 15 20 25
7–8 12.5 15 20
9–10 10 12.5 15
11–12 7.5 10 12.5
13–14 6 7.5 10
15–18 5 5 7.5
19–52 5 5 5
>52 Individual taper Individual taper Individual taper